Your browser doesn't support javascript.
loading
Research on strategy of China pharmaceutical companies coping with competition of authorized generics in American drug market / 中国药学杂志
Chinese Pharmaceutical Journal ; (24): 1217-1222, 2013.
Artículo en Chino | WPRIM | ID: wpr-860319
ABSTRACT

OBJECTIVE:

To study the principle, feature and impact of the authorized generics strategy in American drug market, thus to provide some references for Chinese scholars who research the authorized generics strategy and for China pharmaceutical companies that would face competition in American pharmaceutical market.

METHODS:

By case study and policies analysis, the ways how the brand-name companies used the authorized generics in American drug market were summarized. RESULTS and

CONCLUSION:

Successful authorized generics strategy can maintain a large market share of the brand-name companies products. In American drug market, there are some particularities about the authorize generics strategy due to the features of American drug policies and regulations. China pharmaceutical companies should implement different authorized generics strategy according to their own conditions in American drug market at present.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Pharmaceutical Journal Año: 2013 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Pharmaceutical Journal Año: 2013 Tipo del documento: Artículo